CDKL1 and glioblastoma: Herein, we identified seven robust prognostic markers (SIGLEC14, GHRHR, TAS2R1, CDKL1, ZSCAN10, TBX15, and CD101) that were independent factors significantly correlated with the TTR of the primary GBM samples (Fig. 6A).